- Ecliptasaponin D
-
- $31.00
-
2026-05-11
- CAS:206756-04-9
- Purity: 98.68%
- Supply Ability: 10g
- Ecliptasaponin D
-
-
2023-02-24
- CAS:206756-04-9
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | ecliptasaponin D Basic information |
| Product Name: | ecliptasaponin D | | Synonyms: | ecliptasaponin D;(3beta,16beta)-3-(beta-D-Glucopyranosyloxy)-16-hydroxyolean-12-en-28-oic acid;Olean-12-en-28-oic acid, 3-(β-D-glucopyranosyloxy)-16-hydroxy-, (3β,16β)-;Ecliptasaponin D, 10 mM in DMSO | | CAS: | 206756-04-9 | | MF: | C36H58O9 | | MW: | 634.84 | | EINECS: | | | Product Categories: | | | Mol File: | 206756-04-9.mol |  |
| | ecliptasaponin D Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | color | White to off-white |
| | ecliptasaponin D Usage And Synthesis |
| Uses | Ecliptasaponin D is a triterpenoid glucoside isolated from Eclipta alba (L.) Hassk which is the aerial part of Eclipta prostrate. Eclipta prostrate is considered as a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant and immunomodulatory[1,2]. | | References | [1] Zhang M, et al. [Isolation and identification of ecliptasaponin D from Eclipta alba (L.) Hassk]. Yao Xue Xue Bao. 1997 Aug;32(8):633-4. PMID:11596317
[2] You XY, et al. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice. J Ethnopharmacol. 2015 Dec 4;175:172-80. DOI:10.1016/j.jep.2015.08.034 |
| | ecliptasaponin D Preparation Products And Raw materials |
|